Angion Biomedica (ANGN) IPO Opens Higher

Today's IPO for Angion Biomedica Corp. (NASDAQ: ANGN) opened for trading at $17.62 after pricing 5,000,000 shares of common stock at a public offering price of $16.00 per share.

Cowen and Stifel are acting as joint book-running managers for the offering. H.C. Wainwright & Co. and Oppenheimer & Co. are acting as co-lead managers for the offering.

Angion Biomedica is a late-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics to address acute organ injuries and fibrotic diseases.

You May Also Be Interested In

• Zentalis Pharmaceuticals prices $80.5M public stock offering
• TD Cowen Downgrades Inter Parfums (IPAR) to Hold
• Londian Wason New Energy Tech opens at $26, above IPO price of $22